Gemcitabine and paclitaxel as salvage therapy in metastatic breast cancer

ONCOLOGY

Volumn 15, Issue 2 SUPPL. 3, 2001, Pages 25-27

  Murad, Andre Marcio ^a   Guimarães, Rodrigo Cunha ^b   Aragão, Bruno Cortes ^b   Scalabrinineto, Antonio Orlando ^b   Rodrigues, Victor Hugo ^b   Garcia, Renato ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; ANTINEOPLASTIC ANTIBIOTIC; DEOXYCYTIDINE; DRUG DERIVATIVE; GEMCITABINE; PACLITAXEL;

ADULT; AGED; ARTICLE; BREAST TUMOR; CLINICAL TRIAL; FEMALE; HUMAN; METASTASIS; MIDDLE AGED; PHASE 2 CLINICAL TRIAL; SALVAGE THERAPY; TREATMENT OUTCOME;

ADULT; AGED; ANTIBIOTICS, ANTINEOPLASTIC; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; DEOXYCYTIDINE; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM METASTASIS; PACLITAXEL; SALVAGE THERAPY; TREATMENT OUTCOME;

EID: 0035258884     PISSN: 08909091     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Henderson IC: Chemotherapy of breast cancer: A general overview. Cancer 51:2553-2559, 1983.
2. Hayes DF, Henderson IC, Shapiro CL: Treat-ment of metastatic breast cancer: Present and future prospects. Semin Oncol 22(suppl 5):5-21, 1995.
3. Norton L: Salvage chemotherapy of breast cancer. Semin Oncol 21:19-24, 1994.
4. Holmes FA, Walters RS, Theriault RL, et al: Phase II trial of taxol, an active drug in the treatment of metastatic breast cancer. J Natl Cancer Inst 83:1797-805, 1991.
5. Seidman AD, Tiersten A, Hudis C, et al: Phase II trial of paclitaxel by 3-hour infusion as initial and salvage chemotherapy for metastatic breast cancer. J Clin Oncol 13:2575-2581, 1995.
6. Reichman BS, Seidman AD, Crown JPA, et al: Paclitaxel and recombinant human granulocyte colony-stimulating factor as initial chemotherapy for metastatic breast cancer. J Clin Oncol 11:1943-1951, 1993.
7. Holmes FA, Valero V, Walters RS, et al: The M.D. Anderson Cancer Center experience with Taxol in metastatic breast cancer. Monogr Natl Cancer Inst 15:161-169, 1993.
8. Blackstein M, Vogel CL, Ambinder R, et al: Phase II study of gemcitabine in patients with metastatic breast cancer (abstract 135). Proc Am Soc Clin Oncol 15:117, 1996.
9. Speilmann M, Pouillard P, Espie M, et al: Activity of gemcitabine in metastatic breast cancer in patients previously treated with anthracycline-containing regimens (abstract 143). Breast Cancer Res Treat 41:236, 1996.
10. Carmichael V, Possinger K, Phillip P, et al: Advanced breast cancer: A phase II trial with gemcitabine. J Clin Oncol 13:2713-2736, 1995.
11. Carmichael J, Walling J: Phase II activity of gemcitabine in advanced breast cancer. Semin Oncol 23(suppl 10):77-81, 1996.
12. Possinger K, Kaufmann M, Coleman R, et al: Phase II study of gemcitabine as first-line chemotherapy in patients with advanced or metastatic breast cancer. Anticancer Drugs 10:155-162, 1999.
13. Theodossiou C, Cook J, Fisher, et al: Interaction of gemcitabine with paclitaxel and cisplatin in human tumor cell lines. Int J Oncol 12:825-832, 1998.